FDA.reportPublic FDA data

Application 204721

Type
ANDA
Sponsor
UNIQUE PHARM LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOLTERODINE TARTRATETOLTERODINE TARTRATETABLET;ORAL1MGNoNo
002TOLTERODINE TARTRATETOLTERODINE TARTRATETABLET;ORAL2MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16571-126Tolterodine TartrateTolterodine TartrateRising Pharma Holdings, Inc.ANDACurrent
16571-126Tolterodine TartrateTolterodine TartrateRising Pharma Holdings, Inc.ANDACurrent
16571-127Tolterodine TartrateTolterodine TartrateRising Pharma Holdings, Inc.ANDACurrent
16571-127Tolterodine TartrateTolterodine TartrateRising Pharma Holdings, Inc.ANDACurrent